Koers Accretive Health, Inc. Nyse
Aandelen
US00438V1035
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
||
- USD | - |
08/05 | R1 RCM boekt verlies in Q1, omzet stijgt | MT |
08/05 | Transcript : R1 RCM Inc., Q1 2024 Earnings Call, May 08, 2024 |
Omzet 2024 * | 2,61 mld. 2,42 mld. | Omzet 2025 * | 2,93 mld. 2,72 mld. | Marktkapitalisatie | 5,09 mld. 4,72 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -76 mln. -70,53 mln. | Nettowinst (verlies) 2025 * | 87 mln. 80,74 mln. | EV/omzet 2024 * | 2,68 x |
Nettoschuld 2024 * | 1,91 mld. 1,77 mld. | Nettoschuld 2025 * | 1,61 mld. 1,5 mld. | EV/omzet 2025 * | 2,29 x |
K/w-verhouding 2024 * |
-74,9
x | K/w-verhouding 2025 * |
63,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 35% |
Recentste transcriptie over Accretive Health, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-22 |
Director of Finance/CFO | - | 21-06-22 | |
John Sparby
PSD | President | 48 | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 12-08-19 |
David Dill
BRD | Director/Board Member | 55 | 18-04-21 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01-04-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,68% | 85,55 mld. | |
-29,31% | 70,07 mld. | |
+9,23% | 28,95 mld. | |
-8,63% | 17,51 mld. | |
+2,14% | 17,39 mld. | |
+0,39% | 15,38 mld. | |
+6,47% | 13,4 mld. | |
+68,09% | 12,93 mld. | |
+6,43% | 12,77 mld. |